Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: Indications, histopathology and outcome

BJU International

Volumn 102, Issue 2, 2008, Pages 198-202

  Ong, Teng A ^a,b   Winkler, Mathias H ^b   Savage, Philip M ^b   Seckl, Michael J ^b   Christmas, Timothy J ^c  

^a UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Pathology; Postchemotherapy retroperitoneal lymph node dissection; Survival; Testicular germ cell tumour; Tumour markers

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPH NODE DISSECTION; MALE; NECROSIS; OPERATION DURATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; TERATOMA; TREATMENT OUTCOME;

ADULT; AGED; ALPHA-FETOPROTEINS; ANTINEOPLASTIC AGENTS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; REGRESSION ANALYSIS; RETROPERITONEAL SPACE; SALVAGE THERAPY; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 45449095040     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07533.x     Document Type: Article

References (16)

1. Motzer RJ, Sheinfeld J, Mazumdar M et al. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 2000 18 : 2413 8
2. Mead GM, Cullen MH, Huddart R et al. A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial. Br J Cancer 2005 93 : 178 84
3. Farmakis D, Pectasides M, Pectasides D. Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors. Eur Urol 2005 48 : 400 7
4. Beck SD, Foster RS, Bihrle R, Einhorn LH, Donohue JP. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2005 23 : 6149 56
5. Albers P, Ganz A, Hannig E, Miersch WD, Muller SC. Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 2000 164 : 381 4
6. Coogan CL, Foster RS, Rowland RG et al. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone. Urology 1997 50 : 957 62
7. Eastham JA, Wilson TG, Russell C, Ahlering TE, Skinner DG. Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 1994 43 : 74 80
8. Habuchi T, Kamoto T, Hara I et al. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers. Cancer 2003 98 : 1635 42
9. Kisbenedek L, Bodrogi I, Szeldeli P, Baki M, Tenke P, Horti J. Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapy. Int Urol Nephrol 1995 27 : 325 9
10. Ravi R, Ong J, Oliver RT, Badenoch DF, Fowler CG, Hendry WF. Surgery as salvage therapy in chemotherapy-resistant nonseminomatous germ cell tumours. Br J Urol 1998 81 : 884 8
11. Wood DP Jr, Herr HW, Motzer RJ et al. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer 1992 70 : 2354 7
12. Beck SD, Foster RS, Bihrle R, Einhorn LH, Donohue JP. Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer. Urol Oncol 2005 23 : 423 30
13. Hendry WF, Norman AR, Dearnaley DP et al. Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer 2002 94 : 1668 76
14. Albers PAW, Algaba F, Bokemeyer C et al. Guidelines on Testicular Cancer. Arnhem : European Association of Urology, 2007
15. Hendry WF, A'Hern RP, Hetherington JW, Peckham MJ, Dearnaley DP, Horwich A. Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br J Urol 1993 71 : 208 13
16. Tekgul S, Ozen HA, Celebi I et al. Postchemotherapeutic surgery for metastatic testicular germ cell tumors: results of extended primary chemotherapy and limited surgery. Urology 1994 43 : 349 54